Today

Agents

Chat

Arena

Discover

More

App

Kymera Therapeutics Q2 EPS USD -0.62 - KYMR News | Rallies

Kymera Therapeutics Q2 EPS USD -0.62

KYMR•2026-08-05

Kymera Therapeutics reports second-quarter results

Aug. 5 (Reuters) - Kymera Therapeutics Q2 revenue USD 65 million vs. IBES estimate USD 31.2 million.

Q2 net income USD -61.211 million
Q2 operating expenses USD 140.607 million

Related News

Worthington Enterprises CFO Colin Souza joins Canaccord Genuity Annual Growth Conference fireside chat

WOR•2026-08-05

Flutter Board Announces CEO Transition

FLUT•2026-08-05

W.W. Grainger, Inc. <GWW.N>: Oppenheimer Raises Target Price to $1375 from $1350

•

2026-08-05

Stardust Power Announces Offtake Agreement

SDST•2026-08-05

Rambus Initiates $100 Million Accelerated Share Repurchase Program

RMBS•2026-08-05